What GLP-1 Treatment Costs

What semaglutide and tirzepatide actually cost through clinics and telehealth, and how to avoid hidden fees.

Last updated: Sourcing method: Editorial slot — to be filledReviewed by: Medical reviewer slot — to be assigned

How much does GLP-1 weight-loss treatment cost?

Without insurance, brand-name GLP-1 medication has two cash prices: the retail/list cash price of roughly $1,000–$1,600 per month, and a manufacturer direct self-pay price (through programs like NovoCare and LillyDirect) that is materially lower for those who qualify. Compounded semaglutide or tirzepatide from a licensed 503A/503B pharmacy runs about $200–$500 per month. Most telehealth clinics bundle the medication, consult, and follow-ups into a single monthly fee; in-person programs often bill the consult, labs, and medication separately. What you actually pay depends on the drug, your dose, which pricing channel you use, and whether any of it is covered by insurance. Check current manufacturer self-pay pricing directly at NovoCare and LillyDirect.

GLP-1 weight-loss treatment is priced in two very different worlds: FDA-approved brand-name medication sold by the manufacturer, and compounded semaglutide or tirzepatide mixed by a licensed pharmacy. The gap between them is large, and the real cost of a program is more than the price on the medication itself. This guide breaks down what each layer costs and how to compare clinics on price without getting surprised later.

Brand vs. compounded: the price gap

Semaglutide is sold as Wegovy (weight loss) and Ozempic (type 2 diabetes). Tirzepatide is sold as Zepbound (weight loss) and Mounjaro (type 2 diabetes). At the retail/list cash price, brand medication runs roughly $1,000–$1,600 per month. The manufacturers also run direct self-pay programs (NovoCare, LillyDirect) that price brand product materially lower for those who qualify. Verify the current amount directly, as it changes often. Compounded versions of the same active ingredients, from a licensed 503A or 503B pharmacy, run roughly $200–$500 per month.

Compounded GLP-1s are not FDA-approved. As brand-name shortages resolved, the FDA tightened access to compounded semaglutide and tirzepatide, so availability varies by state and by month. A legitimate clinic will name its compounding pharmacy and disclose 503A vs. 503B status. If it will not name the pharmacy, treat that as a red flag.

Monthly medication cost, brand vs. compounded (cash pay, 2026)
MedicationBrand (retail, cash)Compounded (503A/503B)
Semaglutide (Wegovy / Ozempic)~$1,000–$1,600 / mo$200–$400 / mo
Tirzepatide (Zepbound / Mounjaro)~$1,000–$1,600 / mo$250–$500 / mo

Compounded tirzepatide typically runs $50–$100 more per month than compounded semaglutide. Brand retail figures are before any manufacturer savings card, self-pay program, or insurance. Confirm current manufacturer self-pay and savings-card pricing directly at NovoCare (Novo Nordisk) and LillyDirect (Eli Lilly) before relying on a number.

What actually drives the price

The medication is only part of the bill. When you compare two clinics, four cost drivers explain most of the difference:

  • Brand vs. compounded. The single biggest lever. Compounded is far cheaper but not FDA-approved; brand is FDA-approved but expensive without coverage.
  • Consult and follow-ups. A legitimate program requires a real clinical evaluation before prescribing and ongoing follow-up. Some telehealth plans bundle these into the monthly price; in-person clinics often bill them separately.
  • Labs. Baseline and follow-up labs are part of responsible care. Ask whether labs are included, billed separately, or expected to run through your own insurance.
  • Membership and dose. Some clinics charge a monthly membership on top of medication, and higher maintenance doses can cost more. A low starter price can climb as your dose escalates.

Is cash-pay or insurance cheaper for GLP-1s?

It depends on your plan. Most commercial insurance covers GLP-1s for type 2 diabetes far more readily than for obesity, so many people seeking weight loss end up paying cash. That is a large reason compounded telehealth programs are popular. If your plan does cover a brand GLP-1 for weight loss, insurance is usually cheaper than cash brand pricing. If it does not, a compounded cash program is often the lower total cost. HSA and FSA funds are eligible for GLP-1 therapy at most providers. See our insurance guide for how coverage works.

How to compare clinics on price transparency

Price transparency is one of the seven dimensions we grade clinics on. A clinic that publishes itemized pricing (consult, medication, labs, and any membership) is easier to trust than one that hides pricing behind “book a call.” Before you commit, get clear answers to:

  • Is the price all-inclusive, or are labs and consults billed separately?
  • Is this brand or compounded medication, and which pharmacy fills it?
  • Does the price change as my dose increases?
  • Is there a monthly membership fee on top of the medication?
  • What am I charged if I pause or cancel?

A clinic that answers these plainly, in writing, is showing you the kind of transparency our grades reward. One that dodges them is telling you something too. See how we score pricing transparency in our grading methodology, or compare graded clinics side by side.

This guide is informational and not medical or financial advice. Prices change frequently and vary by clinic, state, and dose. Confirm current pricing directly with the clinic and discuss treatment decisions with a licensed provider.

Frequently Asked Questions

Why is compounded GLP-1 so much cheaper than brand-name?

Compounded semaglutide and tirzepatide are mixed by licensed 503A or 503B pharmacies rather than manufactured and marketed by Novo Nordisk or Eli Lilly, so they skip the brand pricing structure. That is also why they cost roughly $200-$500 a month versus $1,000-$1,600 for brand. Compounded versions are not FDA-approved, and FDA access has tightened as brand shortages resolved, so availability varies by state and month.

What should I budget per month for a GLP-1 program?

A reasonable rule of thumb: budget $250-$500 per month for a compounded telehealth program that bundles medication, consult, and follow-ups, and $500-$1,000 per month for a brand-name in-person program that includes labs and visits. Brand medication paid fully out of pocket, without any savings card or coverage, can exceed $1,000 per month on its own.

Do manufacturer savings cards lower the price?

They can, but only for commercially insured patients, and the terms change often. Novo Nordisk and Eli Lilly publish current savings-card and self-pay pricing on their own sites (NovoCare and LillyDirect). Verify the current amount and eligibility directly with the manufacturer before assuming a price.

What drives the price differences between clinics?

Four things: whether the medication is brand or compounded, your dose (higher maintenance doses can cost more), whether labs and a real consult are included or billed separately, and any monthly membership fee. The cheapest sticker price is not always the cheapest total once labs, consults, and dose escalation are added in.